{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:31:24Z","timestamp":1793968284942,"version":"4.8.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jcyt.2026.102975","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:30:14Z","timestamp":1785799814000},"page":"102975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pretransplant infection associated with inferior survival after TCR\u03b1\u03b2\/CD19-depleted haploidentical HSCT in pediatric nonmalignant disorders"],"prefix":"10.1016","volume":"28","author":[{"given":"Gal","family":"Dadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0746-8636","authenticated-orcid":false,"given":"Etai","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Jacoby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Malkiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphna","family":"Hutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nira","family":"Varda-Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos","family":"Toren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bella","family":"Bielorai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2026.102975_bib0001","volume":"8","year":"2024"},{"key":"10.1016\/j.jcyt.2026.102975_bib0002","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2014-03-563817","article-title":"HLA-haploidentical stem cell transplantation after removal of \u03b1\u03b2+ T and B cells in children with nonmalignant disorders","volume":"124","author":"Bertaina","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2026.102975_bib0003","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.bbmt.2015.07.008","article-title":"Single-center experience of unrelated and haploidentical stem cell transplantation with TCR\u03b1\u03b2 and CD19 depletion in children with primary immunodeficiency syndromes","volume":"21","author":"Balashov","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2026.102975_bib0004","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1182\/bloodadvances.2021005628","article-title":"TCR\u03b1\u03b2\/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders","volume":"6","author":"Merli","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jcyt.2026.102975_bib0005","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jaci.2017.07.008","article-title":"T-cell receptor \u03b1\u03b2+ and CD19+ cell\u2013depleted haploidentical and mismatched hematopoietic stem cell transplantation in primary immune deficiency","volume":"141","author":"Shah","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jcyt.2026.102975_bib0006","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/23744235.2019.1628354","article-title":"Bacille Calmette-Guerin (BCG) complications in children with severe combined immunodeficiency (SCID)","volume":"51","author":"Barkai","year":"2019","journal-title":"Infect Dis"},{"key":"10.1016\/j.jcyt.2026.102975_bib0007","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, Multicenter Standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2026.102975_bib0008","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group Report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2026.102975_bib0009","doi-asserted-by":"crossref","first-page":"394.e1","DOI":"10.1016\/j.jtct.2022.04.002","article-title":"Haploidentical stem cell transplantation after TCR-\u03b1\u03b2+ and CD19+ cells depletion in children with congenital non-malignant disease","volume":"28","author":"Giardino","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jcyt.2026.102975_bib0010","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.bbmt.2019.03.009","article-title":"Haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for primary immunodeficiencies and inherited disorders in children","volume":"25","author":"Neven","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2026.102975_bib0011","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/bloodadvances.2020001729","article-title":"Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide","volume":"4","author":"DeZern","year":"2020","journal-title":"Blood Adv"},{"issue":"10396","key":"10.1016\/j.jcyt.2026.102975_bib0012","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0140-6736(23)00731-6","article-title":"Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium","volume":"402","author":"Thakar","year":"2023","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jcyt.2026.102975_bib0013","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.jcyt.2024.07.007","article-title":"Safety and efficacy of high-dose memory CD45RO+ donor lymphocyte infusion in pediatric recipients after hematopoietic stem cell transplantation","volume":"26","author":"Gasior Kabat","year":"2024","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.jcyt.2026.102975_bib0014","doi-asserted-by":"crossref","first-page":"156.e1","DOI":"10.1016\/j.jtct.2025.10.005","article-title":"Memory T cell donor lymphocyte infusion as a treatment for viral infection after pediatric haploidentical hematopoietic stem cell transplant","volume":"32","author":"Li","year":"2026","journal-title":"Transplant Cell Ther"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926009369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926009369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:23:17Z","timestamp":1793967797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324926009369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S1465324926009369"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102975","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pretransplant infection associated with inferior survival after TCR\u03b1\u03b2\/CD19-depleted haploidentical HSCT in pediatric nonmalignant disorders","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society for Cell & Gene Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102975"}}